Group 5C: Cholangiocarcinoma



Friday, June 10
2:00 pm – 3:30 pm Eastern Time (US/New York)



Mentor: Lisa Craine

Lisa Craine was diagnosed with Stage IV Intrahepactic Cholangiocarcinoma in 2010. She has had 5 recurrences with 8 tumors. Her treatments have included surgeries, chemotherapies and radiation. Lisa spends her days mentoring and advocating for other patients. She is a volunteer Patient Mentor and Research Advocate with The Cholangiocarcinoma Foundation. She is also the Founder of Craine’s Cholangiocarcinoma Crew, a 501(c)3 organization granting 100% of the funds raised to bile duct cancer research. Lisa has completed Advocacy training with The Research Advocacy Network, The Global Liver Institute, AAADV, ASCO, AACR and The Cholangiocarcinoma Foundation. Her mentoring training was completed through The Scott Hamilton Cares Initiative. She is a board member of The Voice of the Patient Advocacy Council for the Cleveland Clinic Taussig Cancer Institute, The Cleveland Clinic Digestive Disease Institute and The Mike Shane Memorial Fund. Lisa has advocated for Liver cancer on Capital Hill with The LIVER Act of 2019, H.R. 3016. Lisa is a George H.W. Bush Points of Light Award Recipient. She has also received recognition from the White House for her volunteer work in cancer advocacy. Her passion is serving others by helping them navigate second opinions, clinical trials and providing support, through hope, love, knowledge and prayers.

Twitter: @lisamariecraine

Scientist: Reham Abdel-Wahab, M.D., Ph.D.

Dr. Reham Abdel-Wahab is an Assistant Professor of Clinical Oncology at Assiut University – Egypt. She obtained her MD, MSc, and Ph.D. degrees and completed her clinical residency and fellowship oncology training at Assiut University. She had five years of postdoctoral fellowship training in the Department of GI Oncology at MD Anderson Cancer Center, The University of Texas. Her current practice at Assiut University – Egypt and her extensive clinical and research experience in GI malignancies. Also, she holds the Chief Scientific Officer position for the Cholangiocarcinoma Foundation, Utah, USA. She is the recipient of the 2018 ASCO Global Young Investigator Award, MD Anderson Cancer Center, Marion Edwards Fellowship Award in Hepatic Oncology, the Leadership Award from the American University of Beirut/Memorial Sloan Kettering Cancer Center course of oncologic sciences, and the technology transfer grant award from the European Society for Radiation Oncology. She is recognized as an expert in hepatobiliary cancers with over 25 published articles, 55 meeting abstracts in national and international meetings, and few book chapters. She is on the editorial board of many journals. She has a record of more than 100 peer reviews in several well-recognized oncology journals.

Twitter: @Dr_R_Abdelwahab